<img height="1" width="1" style="display:none;" alt="" src="https://dc.ads.linkedin.com/collect/?pid=412980&amp;fmt=gif">
LSX-Blog.png

Something Powerful

Tell The Reader More

The headline and subheader tells us what you're offering, and the form header closes the deal. Over here you can explain why your offer is so great it's worth filling out a form for.

Remember:

  • Bullets are great
  • For spelling out benefits and
  • Turning visitors into leads.

Reviewing life sciences deal trends

For the first seven months of this year (to July) our Deal Watch analysis o...

Read More

Navigating M&A transactions in life sciences

An acquisition in the life sciences sector raises various issues, some of w...

Read More

C-suite survey uncovers life sciences challenges

For more than three-quarters (78%) of C-level respondents in the life scien...

Read More

Medius Deal Watch July-August 2018

This issue of Deal Watch focuses on deal activities during the months of Ju...

Read More

A Valuation Expert’s Viewpoint: Life Science Chall...

The Nordic region, as one of the hubs of the life science sector in Europe,...

Read More

PharmaKrysto kickstarts cystinuria drug developmen...

Key learnings: PharmaKrysto has signed a licensing deal with Rutgers Univer...

Read More

Medius Deal Watch June 2018

June has proved to be a very busy month on the deal front with significant ...

Read More

Avacta looks to deals to leverage Affimer platform...

Key learnings: UK-based Avacta Group has developed Affimer® technology, an ...

Read More

Xplico: Supporting strategic decision-making throu...

Key learnings: Headquartered in Copenhagen, Xplico has been providing valua...

Read More

Medius Deal Watch May 2018

This month’s top deals are noticeably in the category of acquisitions rathe...

Read More

What makes for a partner of choice in life science...

Medius Associates publishes a monthly report, Medius Deal Watch, that inclu...

Read More

Have your say in the LSX C-Suite Challenges in Lif...

What are the biggest obstacles to securing financing? What challenges do yo...

Read More

Add Your Response